Manglaviti S, Bini M, Apollonio G, Zecca E, et al. High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors. Lung Cancer 2023;186:107417.
PMID: 37918061